The impact of different culture conditions on biology of primary cancer cells is not always addressed. Here, conditional reprogramming (CRC) was compared with mammaryoptimized EpiCult-B (EpiC) for primary mammary epithelial cell isolation and propagation, allograft generation, and genome-wide transcriptional consequences using cancer and non-cancer mammary tissue from mice with different dosages of Brca1 and p53. Selective comparison to DMEM was included. Primary cultures were established with all three media, but CRC was most efficient for initial isolation (P < 0.05). Allograft development was faster using cells grown in EpiC compared with CRC (P < 0.05). Transcriptome comparison of paired CRC and EpiC cultures revealed 1700 differentially expressed genes by passage 20. CRC promoted Trp53 gene family upregulation and increased expression of epithelial differentiation genes, whereas EpiC elevated expression of epithelial-mesenchymal transition genes. Differences did not persist in allografts where both methods yielded allografts with relatively similar transcriptomes. Restricting passage (<7) reduced numbers of differentially expressed genes below 50. In conclusion, CRC was most efficient for initial cell isolation but EpiC was quicker for allograft generation. The extensive culture-specific gene expression patterns that emerged with longer passage could be limited by reducing passage number when both culture transcriptomes were equally similar to that of the primary tissue. Defining impact of culture condition and passage on the transcriptome of primary cells could assist experimental design and interpretation. For example, differences that appear with passage and culture condition are potentially exploitable for comparative studies targeting specific biological networks in different transcriptional environments.
Introduction
Isolation of primary tumor cells from patient samples is a first step for many types of genetic, biochemical, and pharmacological experiments relevant to personalized cancer treatment (Mitra et al. 2013) . Retention of genetic characteristics and progenitor cells from the original cancer are important goals for culture methodology. Genetically engineered mouse models (GEMM) of breast cancer serve as preclinical translational analogs for the study of breast cancer pathophysiology and technology development for precision medicine. Here, we used Brca1-deficient (Jones et al. 2005 , Nakles et al. 2013a and Brca1-replete (Tilli et al. 2003 , Díaz-Cruz et al. 2011 ) mouse models of breast cancer to compare transcriptional consequences and cancer progenitor cell retention of two different primary cancer epithelial cell culture methodologies: the mammary epithelial cell-optimized EpiCult (B) system (Stemcell Technologies, Vancouver, BC, Canada) (Yamaji et al. 2009 ) and the epithelial-selective conditionally reprogrammed culture (CRC) technology (Liu et al. 2012 , Suprynowicz et al. 2012 , Palechor-Ceron et al. 2013 , Chapman et al. 2014 , Saenz et al. 2014 , Ligaba et al. 2015 . Previously, we employed time-lapse microscopy to show that mammary epithelial cells from wild-type (WT) and Brca1-deficient GEMM undergo morphological changes consistent with epithelial-mesenchymal transition (EMT) within 4 days of initial culture in EpiCult (B) (EpiC) (Nakles et al. 2013b) . The experiments presented here were initiated because CRC was reported to retain cuboidal architecture of the mammary epithelial cell (Saenz et al. 2014) . However, mandatory inclusion of the irradiated fibroblast feeder layer or conditioned media burdens the technique and the required Rho kinase (ROCK) inhibitor Y-27632 has the potential to alter a number of cellular processes (Olson 2008) . For that reason, we considered it sensible to directly compare biological and transcriptional consequences of these two prominent choices for initial isolation and propagation of primary mammary epithelial cells under 2D adherent conditions to further define the advantages and disadvantages of each approach. Previous work reported significant gene expression differences in 3D cultures of undifferentiated human mammary epithelial cells grown as mammospheres compared with growth under differentiating conditions on collagen (Dontu et al. 2003) .
Epithelial-mesenchymal transition (EMT) is observed in many 2D epithelial cell culture conditions and is associated with specific changes in cell morphology and gene expression including upregulation of transforming growth factor beta (TGFB) signaling pathways (MorenoBueno et al. 2009 ) and dedifferentiation, including loss of estrogen receptor alpha (ERa) expression (Novaro et al. 2003) . In cancer biology, EMT has been mechanistically linked to metastasis, chemotherapy resistance, and preservation of cancer progenitor cells (Drasin et al. 2011 , Luo et al. 2015 .
CRC reduces TGFB signaling (Ligaba et al. 2015 ) and promotes p63 expression, a gene linked to 'stemness' in some tissues, but nevertheless expressed in fully differentiated mammary myoepithelial cells (Suprynowicz et al. 2012 , Assefnia et al. 2014 , Chapman et al. 2014 , Melino et al. 2015 . Differentiation of skin keratinocytes is suppressed in CRC with lower levels of keratin gene expression and increased levels of hTERT (Liu et al. 2012 , Palechor-Ceron et al. 2013 , Chapman et al. 2014 . Removal from CRC and placement into alternative media allows the cells to differentiate with increased levels of keratin expression, illustrating that some genetic changes imposed by CRC can be reversible (Suprynowicz et al. 2012) . Treatment of breast cancer cells with the ROCK inhibitor used for CRC, Y-27632, is known to decrease actomyosin interaction (Bhandary et al. 2015) . Actin cytoskeleton changes are integral to EMT (Haynes et al. 2011) .
The natural history of GEMM utilized for this study includes development of a range of triple-negative mammary cancers from moderately well-differentiated to undifferentiated adenocarcinomas and more EMT-like spindloid/sarcomatoid carcinomas (Diaz-Cruz et al. 2010 , Nakles et al. 2013a . The same spectrum of histopathology is found in human triple-negative breast cancers (Lehmann et al. 2011) . One of the human mesenchymal stem-like (MSL) triple-negative histologies demonstrates TGFBR3 over-expression (Jovanović et al. 2014) .
Here, we show that both methodologies can be effectively used for isolation and propagation of primary non-cancer and cancer mammary epithelial cells. The major advantage of the CRC approach was a significantly higher success rate for initial culture (95%). Benefits of EpiC include a less burdensome culture methodology and faster allograft development. Both culture conditions were associated with characteristic transcriptional changes upon prolonged passage (>20). Limiting passage (<7) reduced the magnitude of these changes equivalently for both conditions. Differences found in the paired cells after prolonged culture, for example, variances in allograft formation, upregulation of p53 pathways under CRC, and upregulation of TGFBR3 under EpiC, could be exploited in targeted studies of cancer biology and therapy.
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Materials and methods
Mouse models
Primary mammary epithelial cells were isolated from cancer and non-cancer mammary tissue from six GEMMs and parental strain wild-type (WT) C57Bl/6 mice (30-46 g): Brca1 floxed (fl)11/wild-type (WT)/mouse mammary tumor virus (MMTV)-Cre/Trp53-/+ (Brca1 -/+/p53-/+ ) n = 6/cancer, n = 3/non-cancer; Brca1 fl11/fl11/ MMTV-Cre/Trp53-/+ (Brca1 -/-/p53-/+ ) n = 2/cancer, n = 1/non-cancer; tet-op-CYP19A1 MMTV-reverse tetracycline-controlled transactivator(rtTA) 
(Tag tTA/Esr1 ) n = 1/non-cancer; and WT n = 1/non-cancer. GEMMs were generated at the Georgetown University, weaned before puberty, and genotyped using tail DNA (Transnetyx, Inc, Cordova, TN, USA). For allograft experiments, 6-week-old athymic nude (NU (NCr)-Foxn1nu) female mice (n = 13) (Harlan Laboratories, Inc, Frederick, MD, USA) (26-30 g) were acclimatized 1 week before primary cell injection into thoracic and inguinal mammary fat pads through a skin incision under isoflurane anesthesia (four sites/ mouse/10 6 mammary epithelial cancer cells/site in 25 μL PBS/25 μL Matrigel) (BD Biosciences, Franklin Lakes, NJ, USA)/1cc syringe/27-gauge needle). All mice were housed in barrier zones in single-sex sterilized ventilated cages with corn-cob bedding (1-4 mice per cage) with access to water ad libitum/irradiated Picolab rodent diet 20 (5053) (Labdiet, St Louis, MO, USA) under 12 h darkness:12 h light cycles at the Georgetown University. Irradiated Picolab rodent diet 20 (5053) (Labdiet, St Louis, MO, USA) was provided with the exception of doxycycline-containing diet (Bio-Serv, Frenchtown, NJ, USA) for CYP19A1 p53-/+ mice. Mice were monitored weekly with measurement of palpable tumors and killed by CO 2 inhalation followed by cervical dislocation when mice reached 6 months of age (allograft experiments), 12 months of age (GEMM), or palpable tumors >1 cm 3 , whichever occurred first. Cancer and non-cancer mammary tissues were removed at necropsy and divided for isolation of viable mammary epithelial cells, formalin fixation, or frozen at −80°C.
Primary mammary epithelial cell culture
Cells were isolated using EpiCult-B Mouse Medium Kit (Stemcell Technologies, Vancouver, BC, Canada) (Nakles et al. 2013b ) and divided for culture under CRC: F medium containing 25% Ham's F-12 nutrient mix (Thermo Fisher Scientific) supplemented with 25 ng/mL hydrocortisone, 5 μg/mL insulin, 0.1 nmol/L cholera toxin (Sigma-Aldrich), 0.125 ng/mL epidermal growth factor, 10 μg/mL gentamicin (Thermo Fisher Scientific), 250 ng/mL Fungizone (Thermo Fisher Scientific), and 5 μmol/L ROCK inhibitor Y-27632 (Enzo Life Sciences, Farmingdale, NY, USA) in the presence of irradiated Swiss 3T3-J2 mouse fibroblast feeder cells (Chapman et al. 2010 , Liu et al. 2012 ; or under EpiC: EpiCult-B Basal medium (mouse) supplemented with EpiCult-B Basal Proliferation Supplements (mouse), 10 ng/mL recombinant human epidermal growth factor (rhEGF), 10% fetal bovine serum (FBS) (Stemcell Technologies, Vancouver, BC, Canada), and 100 μg/mL streptomycin/penicillin (Thermo Fisher Scientific) and/or complete Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 μg/mL penicillin, 100 μg/mL streptomycin, and 100 μg/mL glutamine (Thermo Fisher Scientific) at 37°C with 5% CO 2 . For EpiC culture, fibroblast contamination was reduced by incubating cells in a first flask to allow fibroblasts to adhere (3-4 h) and then transferring the epithelial cell enriched non-adherent cells to a second flask for expansion (Darcy et al. 2000) . Cells were viably frozen at different passage numbers and re-cultured when needed. Digital images were taken using EVOS XL Core Cell Imaging System or Olympus IX+71 microscope/ Olympus DP70 camera/DP Controller v3.2.1.276 software (Olympus America Inc, Center Valley, PA, USA).
Immunohistochemistry and pathological examination
Tissue and cell pellets were fixed in 10% buffered formalin (Thermo Fisher Scientific) overnight at 4°C, embedded in paraffin and 5 μm sections were stained with hematoxylin and eosin (H&E), or used for immunohistochemistry (IHC) following antigen retrieval with citrate buffer. The primary antibodies were as follows: cytokeratin, Wide Spectrum Screening (CK) (1:625, Z0622; Dako), cell pellets (1:120), tissue, P53 protein (CM5; Novocastra), NCL-p53-CM5p (1:200), Ki67 NCL+L+Ki67+MM (1:120; Leica), anti-p63 (4A4) mouse monoclonal primary antibody (1:1, 790-4509; Ventana Medical Systems, Inc, Tucson, AZ, USA), transforming growth factor, beta receptor III (TGFBR3) (sc6199, 1:300; Santa Cruz Biotechnology), and cluster of differentiation (CD)140A/platelet-derived growth factor receptor, alpha polypeptide (PDGFRA) (APA5, 1:100; BioLegend, San Diego, CA, USA) to label murine fibroblasts (Gawade et al. 2016) . A board-certified academic pathologist (B.V.S.K.) blinded to sample 23:7 Table 1 Comparison of cancer and non-cancer primary cell culture outcomes. 
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Figure 2 
p53-/+ CRC_6C Undifferentiated adenocarcinoma B207 MG-A No B207 MG-C No B208 MG-A No B208 MG-C No B209 MG-A No B209 MG-C No CYP19A1 p53-/+ EpiC B206 MG-B No B206 MG-D No B207 MG-B Yes AlloCYP19A1 p53-/+ EpiC_7B Undifferentiated adenocarcinoma with spindloid/sarcomatoid features B207 MG-D No B208 MG-B No B208 MG-D No B209 MG-B Yes Undifferentiated adenocarcinoma B209 MG-D No Brca1 -/+/p53-/+ CRC B210 MG-A No Undifferentiated adenocarcinoma B210 MG-B Yes AlloBrca1 -/+/p53-/+ CRC_10B Spindloid/sarcomatoid carcinoma with foci of adenocarcinoma B210 MG-C Yes AlloBrca1 -/+/p53-/+ CRC_10C Spindloid/sarcomatoid carcinoma B210 MG-D No B211 MG-A No B211 MG-B No B211 MG-C Yes AlloBrca1 -/+/p53-/+ CRC_11C Undifferentiated adenocarcinoma B211 MG-D No Brca1 -/+/p53-/+ EpiC B204 MG-A No B204 MG-B
RNAseq
Total RNA was extracted from cell pellets (n = 12), mammary cancers (n = 2), and allografts (n = 10) using TRIzol (Thermo Fisher Scientific) followed by phase separation and precipitation using chloroform and isopropanol (Thermo (GEO) database number GSE81212); and alignment to mouse reference genome (mm9) performed (Kim et al. 2013) . Transcriptomes were assembled, transcript abundance estimated (FPKM: Fragments Per Kilobase of transcript per Million mapped reads), DEGs defined (statistically significant two-fold upregulation or 0.5-fold downregulation) (Cufflinks and Cuffdiff) (Trapnell et al. 2010 (Trapnell et al. , 2012 , and mapped reads visualized (Integrative Genomics Viewer (IGV); Robinson et al. 2011 , Thorvaldsdóttir et al. 2013 . Statistically significant DEGs between individual pairs were identified to define genes that were commonly upregulated in EpiC (n = 913) vs CRC (n = 788) conditions. Allograft transcriptomes were compared with their respective cell culture transcriptome to identify significant DEGs. Genes that were commonly upregulated or downregulated in allografts compared with CRC (up: n = 1364, down: n = 1226) and EpiC (up: n = 143, down: n = 171) primary cultures were then compared to identify the subset of genes commonly upregulated or downregulated irrespective of primary culture/genotype (up: n = 132, down n = 98). Samples were clustered according to their gene expression profiles using the hclust function in R (http://www.R-project.org).
Gene ontology, network analyses, and motif analysis
Gene ontology (GO) was performed using Partek Genomics Suite 6.6, applying Fisher's Exact test, and restricting analyses to groups with more than two genes employing the default mapping method. Top 19 enrichment score categories were extracted for presentation. Hallmark gene sets (Molecular Signatures Database (MSigDB), http://www.broadinstitute.org/ gsea/msigdb/index.jsp) corresponding to commonly upregulated or downregulated DEGs were further analyzed by Pathway Studio to identify expression targets. DNA sequences in promoter regions (−450 bp -TSS -+50 bp) of DEGs upregulated in EpiC vs CRC were analyzed to identify transcription factor binding site (TFBS) motifs. Significantly enriched motifs (P value < 0.001) were recognized utilizing the JASPAR motif database (http://jaspar.genereg.net/) (Kang et al. 2013) . A second search algorithm, PSCAN (Zambelli et al. 2009 ), was used for further validation, and results were visualized as a heat map. Venn diagrams were designed by BioVenn (http://www.cmbi.ru.nl/cdd/ biovenn/) (Hulsen et al. 2008) .
Statistical analyses
Two-tailed Fisher's exact test was used to compare the probabilities of primary culture establishment, allograft development, and correlations between genotypes and allograft histologies; log-rank test was used to test the identity of allograft development time course curves; and Kruskal-Wallis test with Dunn's multiple comparisons test was used to compare the proportion of fibroblasts in the allograft tissues (GraphPad Software). 
Results
Conditional reprogramming culture (CRC) conditions were more successful for initial establishment of primary cultures than EpiCult-B or DMEM CRC methodology was associated with a significantly higher likelihood of establishing primary cultures of mouse mammary epithelial cells (95%) in comparison with EpiCult-B (EpiC) (60%, P = 0.02) and DMEM (35%, P = 0.0003) ( Table 1) . Doubling times were faster for CRC and EpiC compared with DMEM for both cancer and noncancer cells (Fig. 1A) . Brca1 gene dosage did not affect the likelihood of prolonged passage of mammary cancer cells for either CRC or EpiC (Fig. 1B and Table 1 ) (Groeneveld 2012) . Of the nine cancer cell cultures, eight initially established in either CRC or EpiC were successfully moved to DMEM (Table 1) .
Allografts derived from cells cultured under EpiC conditions formed more quickly than those from CRC-cultured cells
Allograft formation was investigated using three paired sequentially passaged (>20) CRC and EpiC primary triplenegative epithelial cancer cell cultures with different Brca1 gene dosages coupled with p53 haploinsufficiency. Palpable allografts developed significantly faster from EpiC compared with CRC cultures (P < 0.05, log-rank, Fig. 2A ). Loss of both Brca1 alleles significantly increased the probability of allograft formation (EpiC, P = 0.007; CRC, P = 0.02; Fisher's Exact; Fig. 2B ) and appearance of uniform spindloid/sarcomatoid histology (P = 0.04; Fisher's Exact; Fig. 2C and Table 2 ). Tumorigenicity occurred earlier and was more variable from EpiC compared with CRC cultures (Fig. 2D) . 
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Spindloid/sarcomatoid cancers demonstrated cytokeratin expression, consistent with epithelial derivation (Fig. 2C,  insets) . Studies of nucleic acids extracted from allograft tissue and/or secondarily cultured cells confirmed the presence of GEMM modifications (Fig. 2E, F, G, H and I ). The proportion of fibroblasts compared with cancer cells was low in allografts (CYP19A1 p53-/+ CRC: 1.5 ± 0, CYP19A1 p53-/+ EpiC: 1.0 ± 0.5; Brca1 -/+/p53-/+ CRC:1.8 ± 0.8, Brca1 -/+/p53-/+ EpiC:
2.3 ± 0.6*; Brca1 -/-/p53-/+ CRC: 0.9 ± 0.4, Brca1 -/-/p53-/+ EpiC: 0.6 ± 0.1* CD140A/PDGFRA-positive fibroblasts per 40× high-power field; values given as mean ± s.e.m., *P < 0.05, Kruskal-Wallis test, Dunn's multiple comparisons test) ( Fig. 2J and K) .
CRC and EpiC in vitro cultures demonstrated dissimilar gene expression patterns with in vivo allograft gene expression more similar to EpiC than CRC
To identify pathways preferentially activated under the different growth conditions, RNAseq was used to characterize transcriptomes of these three paired cell cultures and derived allografts. Hierarchical clustering revealed that culture and growth condition, rather than genetic identity, was the primary determinant of transcriptome similarity. Commonly statistically significantly upregulated DEGs were defined for both EpiC (913) and CRC (788) cultures, independent of genotype (Fig. 3A, B and C) . GO enrichment analyses were performed on these two DEG sets to delineate biological processes and cellular component categories distinctly enriched under the two different culture conditions. More than half (63%) of the top categories identified for each culture condition were unique ( Fig. 4A and B) . Developmental and organismal biological processes were exclusive to EpiC and keratinization to CRC. MSigDB was queried to identify unique hallmark gene sets associated with the DEGs. Epithelial_Mesenchymal_Transition (EMT) was the most significant hallmark gene set for upregulated DEGs in EpiC and P53_Pathway for upregulated DEGs in CRC (Table 3A) .
Hierarchical clustering demonstrated that EpiCand CRC-derived allografts grouped together within the same larger branch as EpiC (Fig. 3A) . To investigate how allograft gene expression patterns differed from cell culture source, DEGs commonly upregulated and downregulated in EpiC-and CRC-derived allografts were compared with their parent cultures. CRC-derived allografts showed a log higher number of DEGs (1364 upregulated and 1226 downregulated) compared with EpiC-derived allografts (143 and 171) (Fig. 3D) . The majority of upregulated (92%) and downregulated (57%) DEGs identified in EpiC-derived allografts were also changed in CRC-derived allografts. GO enrichment analyses demonstrated that all of the top categories 
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Figure 5
Transcription factor binding sites associated with commonly significantly differentially expressed genes under different culture conditions. (A) Scatter plots of transcription factor binding sites (TFBS) enriched motifs identified in DEGs significantly upregulated in EpiC and CRC cultures. All motif occurrences in the DEGs were calculated using the MOODS algorithm with the 130 position-frequency matrices available on the JASPAR website (P value < 0.001). The x-axis and y-axis indicate the mean average of normalized motif enrichment scores and normalized fractions of promoters presented on the y-axis, respectively. Each dot represents a single TFBS and red dots show significantly associated co-TFBSs (normalized proportion >0.2 and average of normalized motif enrichment score >1.5). Note that many of the same TFBS are enriched or depleted under both conditions. HNF1A, hepatocyte nuclear factor 1 homeobox A; PRRX2, paired related homeobox 2; LHX3, LIM homeobox 3; ETS1, V-Ets avian erythroblastosis virus E26 oncogene homolog 1; SP1, Sp1 transcription factor; GABPA, GA binding protein transcription factor, alpha subunit 60 kDa; SPI1, Spi-1 proto-oncogene; KLF4, Kruppel-like factor 4; EGR1, early growth response 1. (B) Venn diagram illustrating the overlap between TFBS significantly enriched in DEGs commonly upregulated in EpiC (red) compared with CRC (blue) cultures. (C) Heat map illustrating relative levels of enrichment vs depletion of the 27 TFBS identified as unique to EpiC (14 TFBS) and CRC (13 TFBS) cultures. EWSR1, EWS RNA-binding protein 1; FLI1, friend leukemia integration 1; RREB1, Ras-responsive element binding protein 1; RELA, V-Rel avian reticuloendotheliosis viral oncogene homolog A; E2F1, E2F transcription factor 1; Rel: V-Rel avian reticuloendotheliosis viral oncogene homolog; NFKB1, nuclear factor of kappa light polypeptide gene enhancer in B-cells 1; PPARG, peroxisome proliferator-activated receptor gamma; Mafb, V-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog B; Bach1, BTB and CNC homology 1, basic leucine zipper transcription factor 1; ZNF, zinc finger protein; MZF1, myeloid zinc finger 1; NR2C2, nuclear receptor subfamily 2, group C, member 2; TLX1, T-cell leukemia homeobox 1; NFICL nuclear factor I/C (CCAAT-binding transcription factor). MyoD, myogenic differentiation; Tcf3, transcription factor 3; Tcf12; transcription factor 12; Myog, myogenin (myogenic factor 4); Myc, V-Myc avian myelocytomatosis viral oncogene homolog; TP63, transforming protein 63; TP53, transforming protein 53; Mycn, V-Myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog; USF1, upstream transcription factor 1; ZEB1, zinc finger E-box binding homeobox 1. (D) Visualization of the six most enriched TFBS motifs identified from DEGs significantly upregulated under EpiC and CRC conditions. TFBS for ZNF263 (also known as ZSCAN12), MZF1_5-13, NFKB1, NR2C2, TLX1::NFIC, and E2F1 were uniquely enriched in genes upregulated under EpiC conditions whereas TFBS for ZEB1, TP53, USF1, TP63, Mycn, and Tcf3 were uniquely enriched under CRC conditions. Norm, normalized.
identified in the upregulated and downregulated DEGs were unique (Fig. 4C and D) . Immune biological processes were exclusive to upregulated DEGs in allografts and motility-related biological processes to the downregulated DEGs. MSigDB analyses demonstrated that the EMT gene set was uniquely identified in DEGs upregulated in CRCderived allografts (Table 3B) 
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condition they were derived from. Immunologically related gene sets (Allograft_Rejection, Interferon_Gamma_ Response, Complement, and Inflammatory_Response) were common to upregulated DEGs for both EpiC-and CRC-derived allografts (Table 3B) .
To explore whether distinct sets of transcription factors (TF) might be responsible for the significantly different DEGs between EpiC and CRC, transcription factor binding site (TFBS) motifs enriched and depleted in the two datasets were examined using the JASPAR database (Kang et al. 2013) and PSCAN (Zambelli et al. 2009 ). The JASPAR database demonstrated that the unique sets of DEGs contained many commonly enriched/ depleted TFBS (Fig. 5A) . Similarly, PSCAN demonstrated that the majority of enriched TFBS were shared (61%) but also identified TFBS relatively enriched under the two culture conditions (Fig. 5B, C and D) . EpiC-enriched TFBS included NFKB1, RELA, and E2F1 sites, TFs positively linked to EMT, the most significant hallmark gene sets. However, the TFBS for another EMT-linked gene, ZEB1, was found relatively enriched under CRC, so there was no perfect correlation between enriched TFBS and hallmark gene sets. CRC-enriched unique TFBS included TP53 and TP63, connecting with the P53_Pathway being the most significant hallmark gene set for CRC.
Corroboration of p53 pathway changes and variance in EMT-related gene expression
The P53_Pathway and Epithelial_Mesenchymal_Transition were selected for focused study because they were the two most significant hallmark gene sets and enriched TFBS corresponding to each category were identified. Fragments Per Kilobase of transcript per Million mapped reads (FPKM) were significantly higher for Trp53 and Trp73 under CRC compared with EpiC conditions (P < 0.05) (Fig. 6A) . Mapped reads were confirmed as corresponding appropriately to the Trp53 and Trp73 exon structures (Fig. 6B) . Trp63 also demonstrates higher FPKM values under CRC compared with EpiC in these cells (Assefnia et al. 2014) , consistent with the reports from others reporting CRC conditions upregulating p63 expression (Suprynowicz et al. 2012 , Chapman et al. 2014 . Immunohistochemical staining intensity, relative numbers of cells staining, and nuclear localization of p53 and p63 were higher in CRC compared with EpiCcultured cells (Fig. 6C) . Hierarchical clustering revealed that samples grouped by culture condition rather than genotype when examining relative expression levels of defined p53-regulated prosurvival and proapoptotic genes (Allen et al. 2014) , consistent with higher activation levels of p53 family members under CRC conditions (Fig. 6D) .
A similar approach was taken for examination of EMTrelated genes. Allograft samples were included because Epithelial_Mesenchymal_Transition was a significant hallmark gene set identified when CRC-derived allograft transcriptomes were compared with those of their parent cultures (Table 3B ). Hierarchical clustering of defined EMT-related genes separated groups by culture and growth condition compared with genotype with allografts clustered more closely to EpiC compared with CRC cultures (Fig. 7A) . Of note, Zeb1 and Zeb2 FPKM levels, TFs that bind TFBS ZEB1 (Fig. 5D) , were significantly lower in CRC compared with EpiC conditions (Fig. 7A) . Because the TGF-β pathway is a defined activator of EMT (Gonzalez & Medici 2014) and previously reported to be downregulated under CRC conditions (Ligaba et al. 2015) , FPKM levels of Tgfb1, 2, and 3 and Tgfbr1, 2, and 3 were specifically included (Fig. 7A) . Tgfbr3 FPKM values were significantly higher under EpiC compared with CRC conditions in all three paired cultures, whereas Tgfb3 was higher in two pairs and Tgfb2 and Tgfbr1 in one ( Fig. 7A  and B) . Tgfbr3 reads mapped appropriately to Tgfbr3 exon structure (Fig. 7C) . Intensity of membrane-localized staining and numbers of cells stained for TGFBR3 using immunohistochemistry were higher in cells cultured under EpiC compared with CRC conditions (Fig. 7D) .
Expression of mammary epithelial cell differentiation genes was not retained in allografts
Genes linked to mammary gland differentiation in vivo were selected for specific examination because retention of mammary epithelial cell differentiation-related gene expression in primary culture and allografts is of interest to mammary gland biologists and breast cancer researchers. Hierarchical clustering indicated that for all but one culture (EpiC: Brca1 -/-/p53-/+ ) the number of differentiation-related genes with higher FPKM values was greatest under CRC conditions followed by EpiC and then allografts (Fig. 8A) . Keratin (K) genes expressed in vivo in human breast cancers (K5,6,7,8,14,18,19) and normal differentiated luminal (K7,8,18,19) and basal (K5,6,14,17) mammary epithelial cells were included in the analyses (Taylor-Papadimitriou et al. 1989 , Trask et al. 1990 , Livasy et al. 2006 , Shao et al. 2012 , Visvader & Stingl 2014 . Overall keratin FPKM levels were highest under CRC conditions, consistent with higher intensity of membrane-localized staining and numbers of cells staining for pan-cytokeratin (Fig. 8B) and identification of Figure 7 Expression levels of epithelial-mesenchymal transition genes were higher under EpiC compared with CRC culture conditions. (A) Dendrogram and heat map of unsupervised hierarchical clustering of FPKM values of epithelial-mesenchymal transition (EMT)-related genes from CYP19A1 p53-/+ , Brca1 -/+/p53-/+ 1, and Brca1 -/-/p53-/+ EpiC and CRC cancer cell cultures and allografts. *One EpiC/CRC pair, **Two EpiC/CRC pairs, ***Three EpiC/CRC pairs, P < 0.05, Cuffdiff_pval. Msn, Moesin. Cdh2, cadherin 2, type 1. Cald1, Caldesmon 1. Tgfb3, transforming growth factor beta 3. Wnt5b: Wnt5b: wingless-type MMTV integration site family, Member 5B. Serpine1, serpin peptidase inhibitor, clade E (Nexin, plasminogen activator inhibitor type 1), member 1. Itgav, integrin, alpha V. Tmem132a, transmembrane protein 132A. Tgfb3, transforming growth factor beta 3. Steap, six-transmembrane epithelial antigen of prostate 2. Tgfbr1, transforming growth factor beta receptor 1. Bmp1, bone morphogenetic protein 1. Col5a2, collagen, type V, alpha 2. Col1a2, collagen, type I, alpha 2. Vcan, versican. Timp1, TIMP metallopeptidase inhibitor 1. Wnt5a, wingless-type MMTV integration site family, member 5A. Tgfb1, transforming growth factor beta 1. Mmp3, matrix metallopeptidase 3. Foxc2, forkhead box C2. Tgfbr3, transforming growth factor beta receptor 3. Sparc, secreted protein, acidic, cysteine-rich (osteonectin). Snai1, snail family zinc finger 1. Zeb2, zinc finger E-box binding homeobox 2. Col3a1, collagen, type III, alpha 1. Twist1, twist family BHLH transcription factor 1. Fn1, fibronectin 1. Itga5, integrin, alpha 5 (fibronectin receptor, alpha polypeptide). Mmp2, matrix metallopeptidase 2. Mmp9, matrix metallopeptidase 9. Zeb1, zinc finger E-box binding homeobox 1. Gng 1, guanine nucleotide binding protein (G Protein), gamma 11. Tcf4, transcription factor 4. Vim, vimentin. Igfbp4, insulin-like growth factor binding protein 4. Tgfbr2, transforming growth factor beta receptor 2. Snai2, snail family zinc finger 2. Tmeff1, transmembrane protein with EGF-like and two follistatin-like domains 1. Ahnak, AHNAK nucleoprotein. Vps13a, vacuolar protein sorting 13 homolog A. 
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keratinization as a unique GO-enriched biological process (Fig. 4B) . Esr1 expression was not significantly altered by culture condition; however, Erbb3 was higher under CRC in all three pairs (Fig. 8A ).
Primary cells cultured for a limited number of passages under either condition maintained gene expression patterns that were not significantly different from source tissue
We next determined whether shortening passage number (P = 7) reduced the number of significantly altered DEGs between the two culture conditions. Cells were isolated from two cancers that developed in the same mouse (Brca -/+/p53-/+/CYP19A1 ). Transcriptomes were compared with each other as well as to the parent cancer from which the cells were derived. There was no clustering by culture or growth condition for EMT-related, mammary differentiation, or p53 pathway genes (Fig. 9A , B and C), and the magnitude of significantly different DEGs between each culture condition and the parent cancer were similar ( Fig. 9D and E) even given the disparate cancer histologies (cancer 1: poorly differentiated adenocarcinoma; cancer 2: spindloid/sarcomatoid carcinoma) (Fig. 9F ). The few commonly significantly upregulated or downregulated DEGs mapped to less than three hallmark gene sets (Allograft_Rejection, Kras_ Signaling_up, and Inflammatory_Response) (Table 3C) . Normal wild-type mammary epithelial cells cultured for three passages before RNAseq analyses showed similar results with few statistically significant DEGs between culture conditions, consistent with the concept of limiting passage number in order to reduce cultureinduced transcriptome changes (O'Driscoll et al. 2006) . Brca1, breast cancer 1, early onset. Gata3, GATA binding protein 3. Krt18, keratin 18, type I. Krt8, keratin 8, type II. Esr1, estrogen receptor 1. Aqp5, aquaporin 5. Stat1, signal transducer and activator of transcription 1, 91 kDa. Csn2, casein beta. Csn1s1, casein alpha S1. Csn1s2a, casein alpha S2-like A, pseudogene. Trp63, tumor protein P63. Erbb2, Erb-B2 receptor tyrosine kinase 2. Krt19, keratin 19, type I. Krt7, keratin 7, type II. Elf3, E74-like factor 3 (Ets domain transcription factor, epithelial-specific). Erbb3, Erb-B2 receptor tyrosine kinase 3. Elf5, E74-like factor 5 (Ets domain transcription factor). Krt6b, keratin 6B, type II. Krt17, keratin 17, type I. Krt5, keratin 5, type II. Krt6a, keratin 6A, type II. Slc34a2, solute carrier family 34 (type II sodium/ phosphate co-transporter), member 2. Krt14, keratin 14, type I. Cidea, cell death-inducing DFFA-like effector A. Wap, whey acidic protein. 
Discussion
The high success rate of CRC for initial primary cell isolation and propagation was consistent with the previous reports (Chapman et al 2010 , Liu et al. 2012 , Saenz et al. 2014 , Ligaba et al. 2015 . Here, we demonstrated that mammary epithelial cells initially isolated in CRC can be transitioned to another culture methodology. An advantage of CRC is that growth of epithelial cells is selectively enhanced under the conditions used here (Liu et al. 2012 ). Therefore, not only did use of CRC for initial isolation rate increase the number of successful cultures, it also reduced fibroblast contamination.
Faster development of allografts with EpiC-cultured cells and acquisition of higher levels of EMT-related gene expression in allografts derived from CRC-cultured cells was consistent with the notion that EMT induces cancer stem cell characteristics in normal and transformed mammary epithelial cells, thereby increasing their tumorinitiating capacity (Mani et al. 2008 ). Higher levels of EMT genes under EpiC compared with CRC conditions paralleled previous reports of EpiC-cultured cells undergoing EMT (Nakles et al. 2013b) in comparison with retention of cuboidal architecture (Saenz et al. 2014) and suppression of the EMT-related TGFB pathway (Ligaba et al. 2015) under CRC conditions. Here, we documented upregulated TGFBR3 expression, a protein linked to a subtype of triplenegative breast cancers in women (Jovanović et al. 2014) , under EpiC conditions. Provocatively, we found that TFBS for ZEB1, an EMT-linked gene, enriched in CRC-associated DEGs. However, FPKM levels for ZEB1 and its paralog ZEB2 were significantly lower in CRC compared with 
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EpiC conditions. Competitive binding between ZEB1 and alternatively acting Nkx2.5 has been described in vascular smooth muscle cells (Ponticos et al. 2004) . A similar mechanism may act under CRC conditions. A second possibility for the absence of ZEB1-associated EMT under CRC conditions is the reported repressive action of p53 on ZEB1/ZEB2 (Sánchez-Tilló et al. 2012) . The significant difference between numbers of injected sites developing into allografts between Brca1-replete and Brca1-deficient cells for both culture conditions may also be linked to EMT. BRCA1 has been described as an EMT suppressor (Bai et al. 2014) .
Reports on the CRC technique have emphasized a link between increased p63 expression and retention of stem/ progenitor cells (Liu et al. 2012 , Suprynowicz et al. 2012 , Chapman et al. 2014 , Brown et al. 2015 , Ligaba et al. 2015 . Here, we showed that in mammary epithelial cancer cells, p63 upregulation is part of a more generalized increase in expression levels of all p53 gene family member genes including Trp53 and Trp73. Faster development of EpiCcultured allografts may have signified that, at least for these cancer cells, higher levels of Trp63 expression was not required for retention of cancer progenitor cells. If the goal for primary mammary epithelial cancer cell culture is allograft generation, the readily applied EpiC culture methodology enhanced allograft development. Presence of Allograft_Rejection as a significant hallmark gene set present in the transcriptomes of allografts and primary cancers was consistent with the expected presence of immune cells in vivo but not in vitro.
Limiting passage number to reduce culture-induced changes is not a new concept (O'Driscoll et al. 2006) . Importantly, here, we showed that if isolation of primary mammary epithelial cells is primarily for transcriptome characterization, the less cumbersome EpiC culture methodology was acceptable. Moreover, we demonstrated that even though CRC promoted retention of epithelial cell architecture, this did not translate to superior preservation of the parent cancer transcriptome.
We documented differential activation of genetic networks linked to cancer biology in the two culture systems, p53 pathway under CRC conditions and TGFB pathway under EpiC conditions. Therapeutic approaches for both these pathways have been developed (Connolly et al. 2012 , Duffy et al. 2014 . A possible future direction would be to compare the response of targeted therapeutics in these paired cultures to establish how modulations in a baseline transcriptome might affect in vitro testing results. It is possible that this could improve the predictability of in vitro testing for some therapeutics (Hwu et al. 2006) .
Studies here focused on triple-negative cancer cells that lack measurable levels of estrogen receptor (ER) alpha protein. A future direction is to explore utilization of these culture methodologies for ER-positive breast cancers. Small-molecule inhibitors of TGFB can increase maintenance of ER alpha expression in primary mammary epithelial cells (Fridriksdottir et al. 2015) . One possibility would be to test how application of TGFB small-molecule inhibitors would influence ER alpha expression levels in these cultures.
In conclusion, both EpiC and CRC culture conditions were used to generate and propagate primary mammary epithelial cell cultures. CRC was the more efficient modality for initial generation and EpiC for allograft generation in these experiments. Because the two conditions result in culture-specific transcriptome alterations, the methodology selected for extended culture may be dictated by the experimental questions that are being posed. It is possible to move from either of these two specialized media to more generic culture condition such as DMEM. Either culture condition can be used to isolate primary mammary epithelial cells for transcriptome inspection, but passage should be limited for best approximation to intact tissue.
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